BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)

NCT02047110 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis (AS)

Interventions

DRUG: placebo for risankizumab
DRUG: risankizumab

Sponsor

AbbVie

Collaborators

[object Object]